iShares MSCI India ETF vs Synopsys, Inc. — how do they compare? iShares MSCI India ETF trades at $46.03 (market cap $5.73B), while Synopsys, Inc. trades at $509.99 (market cap $95.39B). The key difference: Synopsys, Inc. is far larger — about 16.6× iShares MSCI India ETF's market cap, and Synopsys, Inc. is trading nearer its 52-week high, iShares MSCI India ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI India ETF for 58 Days and Synopsys, Inc. for 71 Days on average.
| INDA | SNPS | |
|---|---|---|
Market Cap | $5.73B | $95.39B |
Volume | 6,797,522 | 3,374,903 |
Sector | Broad Market / Factor | Technology |
52-Week High | $55.29 | $534.56 |
52-Week Low | $45.42 | $367.70 |
Typical Hold Time | 58 Days | 71 Days |
Enterprise Value | — | $102.62B |
Signals from Pluang's Aura AI — not financial advice
INDA trades at $45.56, down 1.21% with bearish technical signals dominating. The ETF faces headwinds from India's economic challenges including coal power shortages, below-average monsoon rains, and IT sector weakness. Technical indicators show oversold conditions with RSI readings below 20, while moving averages signal strong bearish momentum. Recent news highlights energy security concerns and pharmaceutical export challenges affecting the underlying Indian market exposure.
The outlook remains cautious given multiple sector-specific pressures in India. Investment opportunity exists for long-term investors betting on India's growth story at depressed levels, but risks include persistent energy shortages, agricultural output concerns, and global trade tensions that could further pressure the ETF's performance in the near term.
Synopsys (SNPS) trades at $497.75, down 0.98% on the day, but maintains strong momentum with three consecutive quarterly earnings beats. The stock shows bullish technical signals with moving averages supporting upward trends, though RSI levels suggest potential overbought conditions. Recent AI partnerships with OpenAI and Amazon, along with raised 2027 guidance, have driven significant investor optimism and a 13% surge in early October 2026.
The outlook remains positive with 93% analyst buy ratings and a $572.54 consensus price target representing 15% upside. Key risks include high valuation multiples (P/E 86.87) and integration challenges from the Ansys acquisition. Revenue growth acceleration to $9.4B projected for 2026 and expanding AI-driven chip design opportunities support the bullish case, though investors should monitor execution on ambitious growth targets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →